FDA approves BioCryst's oral pellet version of swelling disorder drug for children

The U.S. Food and Drug Administration has approved an oral pellet formulation of BioCryst Pharmaceuticals' drug to prevent ...
MPR

FDA Clears New Trofinetide Formulation for Rett Syndrome Treatment

Daybue Stix, a strawberry-flavored trofinetide powder mixable with water-based liquids, gains FDA approval for Rett syndrome treatment.
Pulmonology Advisor

Novel Low-Sodium Oxybate Formulation Under FDA Review

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for TRN-257, a controlled-release, low-sodium oxybate product, for the treatment of c ...

BioCryst Gets FDA Approval To Treat Rare Childhood Swelling Disorder With Oral Drug

BioCryst secures FDA approval for Orladeyo oral pellets, expanding preventive HAE therapy to children ages 2 to under 12.

Antibody formulation could enable simple injections instead of lengthy hospital infusions

Antibody treatments for cancer and other diseases are typically delivered intravenously, because of the large volumes that are needed per dose. This means the patient has to go to a hospital for every ...
Everyday Health

Are Honey Packs for Men Safe?

If you’ve been on social media, you may have heard the buzz about “honey packs.” These honey supplements are mixed with various ingredients and advertised to enhance male sexual performance and fix ...